NY hits $4 billion in marijuana sales; VA medical cannabis patient survey; Study: Medical marijuana for autism; NC public cannabis use policy
Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day.
Your support makes Marijuana Moment possible…
Hold on, just one second before you read today’s news. Have you thought about giving some financial support to Marijuana Moment? If so, today would be a great day to contribute. We’re planning our reporting for the coming months and it would really help to know what kind of support we can count on.
Check us out on Patreon and sign up to give $25/month today:
https://www.patreon.com/marijuanamoment
/ TOP THINGS TO KNOW
Florida activists filed two new marijuana legalization initiatives for the 2028 ballot, a development that comes as a third previously submitted measure to legalize cannabis is also still pending.
The New York Office of Cannabis Management reported that retailers in the state have now sold more than $4 billion worth of recreational marijuana products since the market launched—including nearly $1.5 billion so far this year alone.
The Virginia Cannabis Control Authority is asking medical marijuana patients to complete a “satisfaction survey” about the state’s program—including questions about how the launch of recreational sales will impact them.
A new study conducted by the Minnesota Office of Cannabis Management found that people with autism who use medical marijuana “were able to achieve and maintain symptom relief” for anxiety, depression and sleep.
- “Medical cannabis patients qualified for ASD reported reduced anxiety and a sub-set of patients reported reduced presence/severity of behavioral symptoms after starting medical cannabis.”
The North Carolina Advisory Council on Cannabis is weighing proposed recommendations on how the state should address public use of marijuana if it moves forward with legalization.
Oregon hemp retailers and suppliers are worried that changes to federal laws stand to put them out of business.
- “The CBD products that people are expecting to be available to give to their dogs for arthritis or to give to their parents because they’re aging and have aches and pains that are helped by some of these cannabinoids, they’re not going to have access to them anymore.”
CannaShark Consulting’s Adrian A. Holguin offers advice in a new op-ed for Missouri marijuana microbusiness license applicants on how to avoid getting scammed when signing contracts and deals.
/ FEDERAL
The Government Accountability Office published a report with recommendations on how the Department of Justice and Department of Homeland Security can better collaborate on counternarcotics investigations.
Sen. Pete Ricketts (R-NE) tweeted, “Communist China dominates marijuana markets in America. Its criminal organizations exploit our land, traffic foreign workers, and use prohibited chemicals to produce cannabis. These illicit drug enterprises threaten our communities and national security.”
The Congressional Research Service published an updated report on hemp issues.
/ STATES
A New Jersey senator is being sued by his former chief of staff for allegedly recruiting people to serve as social equity ‘owners’ of marijuana businesses that they did not actually control.
Virginia hemp businesses are asking to withdraw a lawsuit they filed challenging new state product restrictions, saying they plan to refile it in revised form.
Colorado regulators sent an update about adverse health reports linked to cannabis vape products.
Connecticut regulators published guidance about changes to marijuana laws that took effect this month.
Missouri regulators published guidance about testing requirements for ingestible cannabis concentrates.
Illinois regulators published annual cannabis reports.
Minnesota’s Cannabis Expungement Board is seeking a new executive director.
New York regulators approved a new research license to study whether a cannabis-based medicine could provide relief for people with chronic pain.
Michigan regulators revoked a marijuana business’s license and issued a fine over alleged violations.
Oregon regulators will consider changes to hemp product registration rules on October 21.
—
Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.
Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.
—
/ INTERNATIONAL
Trinidad and Tobago lawmakers approved a bill making changes to cannabis, alcohol, tobacco and gambling laws.
Israeli officials are considering limiting the scope of an investigation into Canadian medical cannabis being “dumped” into the country’s market.
/ SCIENCE & HEALTH
A review concluded that the endocannabinoid system “is a promising therapeutic target for endometriosis-associated pain, as it regulates nociception, inflammation, and proliferation.”
A study suggested that “C. sativa hairy root-derived nanovesicles represent a stable immunomodulatory platform with potential applications in cancer immunotherapy and other diseases requiring enhanced cellular immune responses.”
/ ADVOCACY, OPINION & ANALYSIS
The National Rifle Association, Second Amendment Foundation and Firearms Policy Coalition filed an amicus brief urging the Supreme Court to take up a case challenging the federal government’s permanent denial of gun rights to a man over a marijuana cultivation conviction.
/ BUSINESS
Curaleaf International received the first approval from Australian officials for a device intended for the delivery of cannabis extracts via inhalation.
AYR Wellness Inc. completed the first transfer of its Ohio operations into wholly-owned subsidiaries of Arboretum Bidco LLC.
Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox.
Photo courtesy of Chris Wallis // Side Pocket Images.
